The historical rank and industry rank for Sutro Biopharma's Pretax Margin % or its related term are showing as below:
STRO'
s Pretax Margin % Range Over the Past 10 Years
Min: -172.2 Med: -83.45 Max: 2.85
Current: -63.06
STRO's Pretax Margin % is ranked better than 59.77% of 1024
companies
in the Biotechnology industry
Industry Median: -154.935
vs STRO: -63.06
Sutro Biopharma Pretax Margin % Historical Data
The historical data trend for Sutro Biopharma's Pretax Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Competitive Comparison of Sutro Biopharma's Pretax Margin %
For the Biotechnology subindustry, Sutro Biopharma's Pretax Margin %, along with its competitors' market caps and Pretax Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Sutro Biopharma's Pretax Margin % Distribution in the Biotechnology Industry
For the Biotechnology industry and Healthcare sector, Sutro Biopharma's Pretax Margin % distribution charts can be found below:
* The bar in red indicates where Sutro Biopharma's Pretax Margin % falls into.
Sutro Biopharma Pretax Margin % Calculation
Pretax margin - also known as pretax profit margin is the ratio of Pretax Income divided by net sales or Revenue, usually presented in percent.
Sutro Biopharma's Pretax Margin for the fiscal year that ended in Dec. 2023 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
The pretax margin, as know as pretax profit margin, is widely used to measure the operating efficiency of a company before deducting taxes.
The pretax margin is sometimes preferred over the net margin as tax expenditures can make profitability comparisons between companies misleading.
It is a useful tool to compare companies operating in the same sector and less effective when comparing companies from other sectors as each industry generally has different operating expenses and sales patterns.
The long term trend of the pretax margin is a good indicator of the competitiveness and health of the business.
Sutro Biopharma Pretax Margin % Related Terms
Thank you for viewing the detailed overview of Sutro Biopharma's Pretax Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.
Sutro Biopharma (Sutro Biopharma) Business Description
Sutro Biopharma Inc is clinical-stage drug discovery, development, and manufacturing company. It is mainly engaged in the development of biopharmaceutical products. The company manufactures next-generation protein therapeutics for cancer and autoimmune disorders through its proprietary integrated cell-free protein synthesis platform, XpressCF. Products offered by the company include STRO-001 for patients with multiple myeloma and non-Hodgkin lymphoma and STRO-002 for the treatment of ovarian and endometrial cancers.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
STRO has been successfully added to your 